Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Rituximab in Childhood and Juvenile Autoimmune Bullous Diseases As First-Line and Second-Line Treatment: A Case Series of 13 Patients

Fateme Saberi

Fateme Saberi

Assistant Professor of Dermatology

Department Dermatology

School of Medicine

Razi Hospital

Tehran University of Medical Sciences

Related Documents

1. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)

All Documents

1. Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases, Journal of Cutaneous Pathology (2025)

2. Crispr/Cas System: A Powerful Strategy to Improve Monogenic Human Diseases As Therapeutic Delivery; Current Applications and Challenges, Current Gene Therapy (2025)

3. Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial, Journal of Cosmetic Dermatology (2025)

4. Switching Jak Inhibitors: Evaluating Baricitinib’S Effectiveness in Alopecia Areata After Tofacitinib Failure, Archives of Dermatological Research (2025)

5. Bilateral Localized Bullous Pemphigoid in a Young Adult Patient: A Case Report, SAGE Open Medical Case Reports (2023)

6. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)

7. The Pro-Convulsant Effects of Diazinon Low Dose in Male Rats Under Amygdala Kindling, Drug and Chemical Toxicology (2022)